Skip to main content

Table 1 IC50s for OZ277, AS, CQ, PYR and MEF obtained from the aldolase ELISA and the [3H]hypoxanthine method with the P. falciparum strain NF54

From: A new double-antibody sandwich ELISA targeting Plasmodium falciparum aldolase to evaluate anti-malarial drug sensitivity

Anti-malarial compound

Drug assay (n = 3)

IC 50 ± SD (ng/ml)

[3H]hypoxanthine data (ng/ml) from Vennerstrom et al, 2004; Maerki et al, 2006

OZ277

[3H]hypoxanthine

0.36 (± 0.03)

0.91 (± 0.12)

OZ277

Aldolase ELISA

0.63 (± 0.18)

 

AS

[3H]hypoxanthine

0.91(± 0.32)

1.6 (± 0.1)

AS

Aldolase ELISA

1.6 (± 0.3)

 

CQ

[3H]hypoxanthine

3.8 (± 0.5)

5.1 (± 0.8)

CQ

Aldolase ELISA

5.3 (± 0.7)

 

PYR

[3H]hypoxanthine

3.8 (± 0.6)

5.6 (± 0.5)

PYR

Aldolase ELISA

7.9 (± 2.1)

 

MEF

[3H]hypoxanthine

4.3 (± 1.0)

5.8 (± 0.2)

MEF

Aldolase ELISA

6.9 (± 0.5)

 
  1. Geometric mean IC50s with 95% CIs for OZ277, artesunate (AS), chloroquine (CQ), pyrimethamine (PYR) and mefloquine (MEF) determined side-by-side by [3H]hypoxanthine assay and aldolase ELISA. Previously published IC50s for [3H]hypoxanthine assay are given for comparison. Mean values shown from n = 3 independent experiments.